Using flow chemistry to give early drug discovery processes a boost
Webinar hosted in partnership with Chemistry World and Vernalis Research
This webinar demonstrates the capabilities of flow chemistry for researchers in early drug discovery and will look at practical and efficient ways to increase productivity and shorten hit-to-lead times.
Hosted in partnership with Chemistry World, watch the webinar on demand and join Andrew Mansfield, our Flow Chemistry Leader here at Syrris and Lee Walmsley, our guest speaker – and Syrris customer – from Vernalis Research to learn how you can give your early drug discover processes a boost.
-
Enhance the efficiency of early drug discovery, specifically on hit-to-lead approaches
-
Achieve novel diverse chemical space through efficient library generation
-
Case Study: a modern CRO in its lead generation phase of drug discovery
The ever-growing field of flow chemistry has proved itself invaluable in many industries using synthetic chemistry, particularly in pharma during drug discovery. However, the industry has been slow to adopt flow chemistry techniques in the hit-to-lead phase. The potential benefits of implementing these methods are immense, especially for expediting lead generation and overcoming challenging chemistries that were previously difficult to achieve via traditional batch processes.
Discover how pioneering modular flow chemistry technologies can unlock the potential for discovery chemists to accelerate research, includng efficient ways to increase productivity and shorten hit-to-lead times in this webinar from Syrris and Vernalis Research.
- Accelerate research and shorten hit-to-lead time
Meet the speakers
About the speakers
Andrew is the Flow Chemistry Leader at Syrris. Andrew has a background in implementing new chemical technologies across pharma and academia, with a major interest in the application of flow chemistry. At Syrris, Andrew manages and develops the flow chemistry portfolio.
Lee is the Senior Team Leader at Vernalis Research, leading global drug discovery projects in collaboration with Vernalis partners. Additionally, Lee leads the Vernalis Technology Team, which establishes and champions flow chemistry capabilities, and exploits new methods in medicinal chemistry to augment existing fragment approach, and SBDD capabilities.